MSCI (NYSE:MSCI) Now Covered by Wolfe Research

Equities researchers at Wolfe Research assumed coverage on shares of MSCI (NYSE:MSCI) in a research note issued to investors on Tuesday, MarketBeat reports. The brokerage set a “peer perform” rating on the technology company’s stock.

A number of other brokerages have also weighed in on MSCI. Royal Bank of Canada upped their target price on MSCI from $588.00 to $638.00 and gave the stock an “outperform” rating in a research note on Wednesday, January 31st. Redburn Atlantic lowered MSCI from a “neutral” rating to a “sell” rating and decreased their target price for the stock from $620.00 to $470.00 in a research note on Tuesday, February 20th. Raymond James restated a “market perform” rating on shares of MSCI in a research note on Friday, January 5th. Morgan Stanley upgraded MSCI from an “equal weight” rating to an “overweight” rating and upped their target price for the stock from $526.00 to $600.00 in a research note on Wednesday, December 13th. Finally, StockNews.com lowered MSCI from a “buy” rating to a “hold” rating in a research note on Tuesday, February 20th. Three analysts have rated the stock with a sell rating, five have assigned a hold rating and eight have issued a buy rating to the company. According to data from MarketBeat, the company has an average rating of “Hold” and an average target price of $578.21.

MSCI Stock Performance

NYSE:MSCI opened at $557.00 on Tuesday. MSCI has a 52-week low of $451.55 and a 52-week high of $617.39. The firm has a market cap of $44.13 billion, a price-to-earnings ratio of 38.68, a PEG ratio of 2.77 and a beta of 1.07. The business’s fifty day moving average is $565.42 and its 200 day moving average is $537.61.

MSCI (NYSE:MSCI) last released its quarterly earnings data on Tuesday, January 30th. The technology company reported $3.68 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $3.29 by $0.39. The company had revenue of $690.11 million for the quarter, compared to analyst estimates of $662.64 million. MSCI had a negative return on equity of 111.17% and a net margin of 45.42%. The firm’s revenue for the quarter was up 19.8% compared to the same quarter last year. During the same period in the previous year, the company posted $2.84 EPS. Equities analysts predict that MSCI will post 14.8 EPS for the current fiscal year.

Institutional Investors Weigh In On MSCI

Several institutional investors have recently bought and sold shares of the stock. Parkside Financial Bank & Trust raised its position in shares of MSCI by 12.2% in the 4th quarter. Parkside Financial Bank & Trust now owns 165 shares of the technology company’s stock worth $93,000 after acquiring an additional 18 shares in the last quarter. Legacy Advisors LLC raised its position in shares of MSCI by 2.8% in the 4th quarter. Legacy Advisors LLC now owns 664 shares of the technology company’s stock worth $376,000 after acquiring an additional 18 shares in the last quarter. Quent Capital LLC raised its position in shares of MSCI by 23.5% in the 4th quarter. Quent Capital LLC now owns 100 shares of the technology company’s stock worth $57,000 after acquiring an additional 19 shares in the last quarter. KB Financial Partners LLC raised its position in shares of MSCI by 8.1% in the 2nd quarter. KB Financial Partners LLC now owns 253 shares of the technology company’s stock worth $119,000 after acquiring an additional 19 shares in the last quarter. Finally, Balentine LLC raised its position in shares of MSCI by 3.6% in the 3rd quarter. Balentine LLC now owns 572 shares of the technology company’s stock worth $293,000 after acquiring an additional 20 shares in the last quarter. 89.97% of the stock is currently owned by hedge funds and other institutional investors.

About MSCI

MSCI Inc, together with its subsidiaries, provides critical decision support tools and solutions for the investment community to manage investment processes worldwide. The Index segment provides indexes for use in various areas of the investment process, including indexed financial product, such as ETFs, mutual funds, annuities, futures, options, structured products, and over-the-counter derivatives; performance benchmarking; portfolio construction and rebalancing; and asset allocation, as well as licenses GICS and GICS Direct.